Suchergebnisse - "Buti, Maria"

PubPharm (46)

1

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1) : a multicentre, double-blind, active-controlled, randomised, phase 2b trial

enthalten in: The lancet. Gastroenterology & hepatology | 2023

von Yuen, M. | Asselah, T. | Jacobson, I. | +116

CommentIn: Lancet Gastroenterol Hepatol. 2023 Sep;8(9):772-773. - PMID 37442151

2

Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection

enthalten in: Gut | 2023

von Janssen, H. | Hou, J. | Asselah, T. | +16

3

Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection

enthalten in: The New England journal of medicine | 2022

von Yuen, M. | Lim, S. | Plesniak, R. | +132

CommentIn: N Engl J Med. 2022 Nov 24;387(21):1996-1998. - PMID 36346068

4

Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B

enthalten in: The Journal of infectious diseases | 2021

von Hsu, Y. | Yeh, M. | Wong, G. | +27

5

Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2019

von Marcellin, P. | Wong, D. | Sievert, W. | +14

6

JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis : OMEGA-1

enthalten in: Hepatology (Baltimore, Md.) | 2019

von Zeuzem, S. | Bourgeois, S. | Greenbloom, S. | +19

7

Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy : a prespecified follow-up analysis of two randomised trials

enthalten in: The lancet. Gastroenterology & hepatology | 2019

von Buti, M. | Wong, D. | Gane, E. | +11

CommentIn: Lancet Gastroenterol Hepatol. 2019 Apr;4(4):260-262. - PMID 30795959

8

Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a : Week 120 Analysis

enthalten in: Digestive diseases and sciences | 2018

von Ahn, S. | Marcellin, P. | Ma, X. | +19

ErratumIn: Dig Dis Sci. 2018 Oct 15;:. - PMID 30324553

9

Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis

enthalten in: Gastroenterology | 2018

von Esteban, R. | Pineda, J. | Calleja, J. | +19

CommentIn: Gastroenterology. 2018 Oct;155(4):969-971. - PMID 30201359

10

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

enthalten in: Journal of hepatology | 2018

von Agarwal, K. | Brunetto, M. | Seto, W. | +28

1
2
3
4
5
Nächster »
[5]